Aurora Cannabis TSE:ACB Dividend History

So there are a comparatively high number of producers and retailers serving a market that’s quite limited, at the end of the day. North America is expected to hold the highest cannabis market share in the global market in 2028. The cannabis flower/bud segment is expected to be the leading segment based on type in the global market during the forecast period. Contributing original what are bear and bull markets content and curating quality news on only the most promising cannabis companies and the most influential investors. It uses the current share price and divides it by the total earnings per share for the last 12 months. Dividend Per Share is a financial indicator equal to the ratio of the company’s net profit available for distribution to the annual average of ordinary shares.

Like I stated before, there will be a shakeout and the management teams that come to terms with reality sooner than most and those that are best at cost-cutting will win the long game. It seems like ACB doesn’t have any back-up plan if their current strategy fails. Bizarrely, management has said in the Q4 conference call that they saw no pricing pressure. I think that this can mean two things, either it is as oblivious as it has proven itself over the past years with its aggressive expansion, or they desperately want to hold onto the ridiculous valuation of the stock. This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of use, Privacy and Disclaimer policies.

It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. Aurora is the second largest cannabis company in the world by market capitalization, after Canopy Growth Corporation. The company began trading on the NYSE on October 23, 2018 using the ticker ACB. Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities.

Will Cannabis Entrepreneurs Switch To Psychedelics?

Many states declared that the use of medical marijuana is permissible, and medical marijuana dispensaries are being declared as essential businesses. Others, such as California, Oregon, and Colorado states in the United States, have allowed dispensaries and recreational stores to remain open despite their stay-at-home orders. In Europe, as concerns about COVID-19 increased and countries began implementing lockdown measures, consumers stocked up their products.

• When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
• Speaking of the trade association for cannabis retailers, they issue informative opinion pieces on what goes right and wrong in the Canadian market.
• This site cannot substitute for professional investment advice or independent factual verification.
• Second, positive adjusted EBITDA is a fairly low goal given the routine net profitability of a great many Canadian and U.S. publicly traded companies.

A report in mid-September 2018 by BNN Bloomberg, stated that Coca-Cola was considering the development of cannabis-infused beverages for medical purposes (with a non-psychoactive ingredient, CBD) and was in preliminary discussion with Aurora. Although Coke and Aurora then announced that they were merely studying the market, and had no plan to announce regarding the distribution of such products. Aurora’s shares increased and its market cap reached US$10.71 billion on September 18, 2018. On 20 September 2018, Tilray had become the world’s most valuable cannabis company, but a major drop in share price (and a subsequent market capitalization of about US$10 billion) made it only the third largest, after Canopy Growth and Aurora.

Real-time analyst ratings, insider transactions, earnings data, and more. The company’s average rating score is 2.00, and is based on 1 buy rating, 8 hold ratings, and 1 sell rating. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. Meanwhile, there’s no reason to believe that scores of competitors will either consolidate, or drop out of the over-served Canadian market.

Aurora Cannabis Stock Predictions

Construction on the Nordic 2 project in Denmark was stopped in November 2019 when the company’s stock dropped to a two year low. On November 13, 2017, Aurora Cannabis delivered an all-stock takeover bid to CanniMed Therapeutics’s board of directors, which became public on November 14. CanniMed management exploration and production sub responded by rejecting the offer, and proposed an alternative merger with Newstrike Resources, a recreational cannabis firm, instead. CanniMed also enacted a “poison pill” to fend off the acquisition by enacting a rights plan that would allow CanniMed shareholders to vote on the Newstrike deal.

• Marijuana flower, or “bud,” is the most popular consumable product in the global marketplace.
• This is projected to increase its sales and opens up new revenue channels for companies in the region.
• HEXO has moved to Tier 1 from Tier 2, while several names have moved from Tier 2 to Tier 3.
• Ltd. (0.79%), TD Asset Management Inc. (0.31%), JPMorgan Chase & Co. (0.31%), Public Sector Pension Investment Board (0.31%) and Swiss National Bank (0.30%).
• Aurora is the second largest cannabis company in the world by market capitalization, after Canopy Growth Corporation.

It would have distribution agreements in a number of countries, including Germany, Italy, Brazil and Australia. At its year-end in June 2019, Aurora had a market capitalization of US$4.8 billion. An October 2019 report stated that cannabis stocks had “crumbled to their lowest level since 2017”; Aurora shares were also at a two year low. The average rating score is and is based on 1 buy ratings, 2 hold ratings, and 2 sell ratings. According to the current price, Aurora Cannabis is 103.57% away from the 52-week low. According to the current price, Aurora Cannabis is 13.36% away from the 52-week high.

Akanda pivots to German market as cannabis reform gains traction

It is the most widely cultivated, trafficked, and consumed drug worldwide, according to the United Nations Office on Drugs and Crime . With every lot, there are small variations in the THC & CBD percentage of the plant. Because of this, when you see our products they will offer you a range that the plant will be in, but not an exact number. Cannabis NL and its partners are pleased to offer new products on a regular basis. Global X Management Company LLC serves as an advisor to Global X Funds.

This includes after tax income on equity and labor invested in the business. The corresponding ‘margin’ per company is 8.5% on average, which includes wages for two owners on average. This makes sense to me, as it is hard to make serious money in agriculture, no matter how highly advanced, productive or innovative the sector is compared to open field agriculture. Let’s try for a moment to apply this 8.5% to Aurora after adjusting for owner labor. The coronavirus pandemic provided opportunities to support the industry and relax regulations. In 2020, the House of Representatives passed the HEROES Act and presented it to the Senate, including the SAFE Banking Act.

Should I buy or sell ACB stock?

The Funds are distributed by SEI Investments Distribution Co. , which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG. Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.

The Aurora Cannabis stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.31 and $1.53. A sell signal was issued from a pivot top point on Monday, September 12, 2022, and so far it has fallen -27.95%. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally.

Aurora owns Pedanios GmbH, a wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Berlin, Germany. Pedanios is the EU’s largest distributor of cannabis by volume of product sold. As of March 2018, it is one of three distributors to offer cannabis flowers sourced from both Canada and the Netherlands. Aurora claimed it had reduced the cost of producing cannabis to $0.85 per gram, when the national retail price of cannabis in Canada was $7.37 per gram.

Aurora Sky was sold to Bevo Agtech in 2022, following a transaction in which Aurora took a 50.1 per cent stake in that company. It is a 55,200-square-foot production facility in Mountain View County. In January, 2018, Aurora became the first private company to be granted a supply agreement to the Italian market through its German subsidiary Pedanios. Aurora announced on January 23, 2018 that the first tender would consist of three lots of different cannabinoid profiles totalling 100 kg. Out of 2 analysts, 0 (0%) are recommending ACB as a Strong Buy, 0 (0%) are recommending ACB as a Buy, 2 (100%) are recommending ACB as a Hold, 0 (0%) are recommending ACB as a Sell, and 0 (0%) are recommending ACB as a Strong Sell. I understand that I will be billed $499 monthly if I choose to continue.

Medical hemp has gained a lot of worldwide attention in recent years. Sativa continue to grow, as evident by an increasing number of countries and states permitting its use for specific medical indications. Countries such as Germany, Finland, Israel, and Canada have taken bold steps in allowing medical marijuana use, owing to its therapeutic benefits. Additionally, more than 25 states in the U.S. have changed their laws to legalize canabis for medical use. In California and Florida, the product has been successfully used by mainstream doctors to treat AIDS, anorexia, arthritis, and even cancer. The ongoing research and clinical trials for several marijuana-based medications are further expected to fuel the market’s growth in forthcoming years.

Recent News

The producers will need to make cash flow, and at some point, they will push their inventory onto the market regardless of pricing. Like I said before, there will be capacity rationalization and bankruptcies. Aurora’s production facilities would potentially be not the worst-positioned due to their scale, but Aurora does have a large overhead and is incurring high development costs for new products. As any economics textbook can tell you, commodity producers will not earn a return that is higher than their cost of capital.

Successful closing of Series B Financing Round Berlin-based Sanity… The EV / EBITDA ratio shows the ratio of the cost to its profit before tax, interest and amortization . EPS shows how much of the net profit is accounted for by the common share. Aurora Cannabis euro to swedish krona exchange rate convert eur stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada. South America is expected to witness substantial growth due to the rapidly changing government policies and legalization of recreational hemp in various countries like Uruguay and Chile, among others. Social movements in favor of legalization were some of the key factors that led to this perspective towards the product through policies and legislation. Furthermore, several new startups are embarking on research, development, and production of the product. In the next monthly review, we will summarize the performance for December and discuss any additions or deletions.

Cantor trims Aurora Cannabis price target, reiterates overweight rating

The takeover was finalized in January 2018, based on a Can$1.1 billion deal. The subsequent plan to purchase MedReleaf was expected to make the company the largest in Canada with a market capitalization of approximately $7 billion. Competitor Canopy Growth Corporation’s market value exceeded that amount by $3.7 billion, however after a partial takeover by Constellation Brands was announced in late August 2018.